236 related articles for article (PubMed ID: 28557543)
21. Hepcidin Is Essential for Alveolar Macrophage Function and Is Disrupted by Smoke in a Murine Chronic Obstructive Pulmonary Disease Model.
Perez E; Baker JR; Di Giandomenico S; Kermani P; Parker J; Kim K; Yang J; Barnes PJ; Vaulont S; Scandura JM; Donnelly LE; Stout-Delgado H; Cloonan SM
J Immunol; 2020 Nov; 205(9):2489-2498. PubMed ID: 32958690
[TBL] [Abstract][Full Text] [Related]
22. Cigarette smoke alters the ability of human dendritic cells to promote anti-Streptococcus pneumoniae Th17 response.
Le Rouzic O; Koné B; Kluza J; Marchetti P; Hennegrave F; Olivier C; Kervoaze G; Vilain E; Mordacq C; Just N; Perez T; Bautin N; Pichavant M; Gosset P
Respir Res; 2016 Jul; 17(1):94. PubMed ID: 27460220
[TBL] [Abstract][Full Text] [Related]
23. [Effects of PI3Kδ-RhoA pathway on phagocytosis defect of alveolar macrophages in a mouse model of chronic obstructive pulmonary disease].
Hu ST; Xia Q; Zeng XL; Bao HR; Liu XJ
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Jul; 40(7):520-526. PubMed ID: 28728277
[No Abstract] [Full Text] [Related]
24. Reduced transient receptor potential vanilloid 2 expression in alveolar macrophages causes COPD in mice through impaired phagocytic activity.
Masubuchi H; Ueno M; Maeno T; Yamaguchi K; Hara K; Sunaga H; Matsui H; Nagasawa M; Kojima I; Iwata Y; Wakabayashi S; Kurabayashi M
BMC Pulm Med; 2019 Mar; 19(1):70. PubMed ID: 30914062
[TBL] [Abstract][Full Text] [Related]
25. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model.
Harvey CJ; Thimmulappa RK; Sethi S; Kong X; Yarmus L; Brown RH; Feller-Kopman D; Wise R; Biswal S
Sci Transl Med; 2011 Apr; 3(78):78ra32. PubMed ID: 21490276
[TBL] [Abstract][Full Text] [Related]
26. Identification of Siglec-1-negative alveolar macrophages with proinflammatory phenotypes in chronic obstructive pulmonary disease.
Saito T; Fujino N; Kyogoku Y; Yamada M; Okutomo K; Ono Y; Konno S; Endo T; Itakura K; Matsumoto S; Sano H; Aizawa H; Numakura T; Onodera K; Okada Y; Hussell T; Ichinose M; Sugiura H
Am J Physiol Lung Cell Mol Physiol; 2024 Jun; 326(6):L672-L686. PubMed ID: 38530936
[TBL] [Abstract][Full Text] [Related]
27. Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease.
Berenson CS; Kruzel RL; Eberhardt E; Sethi S
J Infect Dis; 2013 Dec; 208(12):2036-45. PubMed ID: 23908477
[TBL] [Abstract][Full Text] [Related]
28. The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD.
Ween MP; White JB; Tran HB; Mukaro V; Jones C; Macowan M; Hodge G; Trim PJ; Snel MF; Hodge SJ
Sci Rep; 2021 Feb; 11(1):4106. PubMed ID: 33602992
[TBL] [Abstract][Full Text] [Related]
29. [The effect of fine particles on the phagocytosis of alveolar macrophages potentially by Arp2/3 complex in a mouse model of chronic obstructive pulmonary disease].
Huo SJ; Hu Y; Zeng XL; Bao HR; Liu XJ
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):907-915. PubMed ID: 31826534
[No Abstract] [Full Text] [Related]
30. Human Rhinovirus Impairs the Innate Immune Response to Bacteria in Alveolar Macrophages in Chronic Obstructive Pulmonary Disease.
Finney LJ; Belchamber KBR; Fenwick PS; Kemp SV; Edwards MR; Mallia P; Donaldson G; Johnston SL; Donnelly LE; Wedzicha JA
Am J Respir Crit Care Med; 2019 Jun; 199(12):1496-1507. PubMed ID: 30562053
[No Abstract] [Full Text] [Related]
31. Glucocorticoid-Augmented Efferocytosis Inhibits Pulmonary Pneumococcal Clearance in Mice by Reducing Alveolar Macrophage Bactericidal Function.
Stolberg VR; McCubbrey AL; Freeman CM; Brown JP; Crudgington SW; Taitano SH; Saxton BL; Mancuso P; Curtis JL
J Immunol; 2015 Jul; 195(1):174-84. PubMed ID: 25987742
[TBL] [Abstract][Full Text] [Related]
32. Potential Link between the Sphingosine-1-Phosphate (S1P) System and Defective Alveolar Macrophage Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD).
Barnawi J; Tran H; Jersmann H; Pitson S; Roscioli E; Hodge G; Meech R; Haberberger R; Hodge S
PLoS One; 2015; 10(10):e0122771. PubMed ID: 26485657
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis inhibitor of macrophage (AIM) expression in alveolar macrophages in COPD.
Kojima J; Araya J; Hara H; Ito S; Takasaka N; Kobayashi K; Fujii S; Tsurushige C; Numata T; Ishikawa T; Shimizu K; Kawaishi M; Saito K; Kamiya N; Hirano J; Odaka M; Morikawa T; Hano H; Arai S; Miyazaki T; Kaneko Y; Nakayama K; Kuwano K
Respir Res; 2013 Mar; 14(1):30. PubMed ID: 23497247
[TBL] [Abstract][Full Text] [Related]
34. Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD).
Eapen MS; Hansbro PM; McAlinden K; Kim RY; Ward C; Hackett TL; Walters EH; Sohal SS
Sci Rep; 2017 Oct; 7(1):13392. PubMed ID: 29042607
[TBL] [Abstract][Full Text] [Related]
35. Reactivity of mouse alveolar macrophages to cigarette smoke is strain dependent.
Vecchio D; Arezzini B; Pecorelli A; Valacchi G; Martorana PA; Gardi C
Am J Physiol Lung Cell Mol Physiol; 2010 May; 298(5):L704-13. PubMed ID: 20154225
[TBL] [Abstract][Full Text] [Related]
36. [Effects of mTOR-Cdc42 signaling pathway on phagocytosis of alveolar macrophages in chronic obstructive pulmonary disease mice].
Wang YJ; Liu XJ; Dang MM; Zeng XL; Bao HR
Zhonghua Yi Xue Za Zhi; 2016 Dec; 96(46):3745-3750. PubMed ID: 27998433
[No Abstract] [Full Text] [Related]
37. Response of alveolar macrophages from inducible nitric oxide synthase knockout or wild-type mice to an in vitro lipopolysaccharide or silica exposure.
Zeidler PC; Roberts JR; Castranova V; Chen F; Butterworth L; Andrew ME; Robinson VA; Porter DW
J Toxicol Environ Health A; 2003 Jun; 66(11):995-1013. PubMed ID: 12775513
[TBL] [Abstract][Full Text] [Related]
38. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers.
Löfdahl JM; Wahlström J; Sköld CM
Clin Exp Immunol; 2006 Sep; 145(3):428-37. PubMed ID: 16907910
[TBL] [Abstract][Full Text] [Related]
39. Reduced number and morphofunctional change of alveolar macrophages in MafB gene-targeted mice.
Sato-Nishiwaki M; Aida Y; Abe S; Shibata Y; Kimura T; Yamauchi K; Kishi H; Igarashi A; Inoue S; Sato M; Nakajima O; Kubota I
PLoS One; 2013; 8(9):e73963. PubMed ID: 24040127
[TBL] [Abstract][Full Text] [Related]
40. Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance.
Marriott HM; Bingle CD; Read RC; Braley KE; Kroemer G; Hellewell PG; Craig RW; Whyte MK; Dockrell DH
J Clin Invest; 2005 Feb; 115(2):359-68. PubMed ID: 15650769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
